tetano
Editor, Senior Moderator
J Mol Cell Cardiol. 2020 Apr 24. pii: S0022-2828(20)30117-6. doi: 10.1016/j.yjmcc.2020.04.026. [Epub ahead of print]
COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know.
Dhawan R[SUP]1[/SUP], Gundry RL[SUP]2[/SUP], Brett-Major DM[SUP]3[/SUP], Mahr C[SUP]4[/SUP], Thiele GM[SUP]5[/SUP], Lindsey ML[SUP]6[/SUP], Anderson DR[SUP]7[/SUP].
Author information
KEYWORDS:
ACE; Angiotensin converting enzyme inhibitors; Angiotensin converting enzyme receptor 2; COVID-19; Cardiovascular disease; Coronavirus; Renin angiotensin system
PMID:32339565DOI:10.1016/j.yjmcc.2020.04.026
COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know.
Dhawan R[SUP]1[/SUP], Gundry RL[SUP]2[/SUP], Brett-Major DM[SUP]3[/SUP], Mahr C[SUP]4[/SUP], Thiele GM[SUP]5[/SUP], Lindsey ML[SUP]6[/SUP], Anderson DR[SUP]7[/SUP].
Author information
KEYWORDS:
ACE; Angiotensin converting enzyme inhibitors; Angiotensin converting enzyme receptor 2; COVID-19; Cardiovascular disease; Coronavirus; Renin angiotensin system
PMID:32339565DOI:10.1016/j.yjmcc.2020.04.026